The research, led by Dr. Elena Jimenez-Ruiz at LMU’s Faculty of Veterinary Medicine and published in Nature Communications, identifies two lysine methyltransferases in T. gondii that become active in sequence at the pointed, apical end of the parasite. The first enzyme, newly characterized and named PCKMT, positions the actin nucleator Formin-1 at the parasite tip. This localization allows actin filaments to be assembled locally and enables the protrusion of the conoid, a specialized structure at the parasite’s apex that plays a central role in invasion. A second methyltransferase, AKMT, then participates in downstream reorganization events that couple the newly built actin network to the machinery that transmits force. In other words, the enzymes do not merely decorate proteins at random: they appear to operate in a defined sequence, each preparing the ground for the next stage of motility.

“What surprised us is that methylation is not acting here in the nucleus, where it is best known, but directly at the parasite’s motility machinery,” Jimenez-Ruiz explains. “These two enzymes appear to organize the transition from a parasite that is prepared to move to one that can actually generate force.”

Lysine methylation is a well-established regulatory mechanism in cell biology, but it is most famous for its role in the cell nucleus, where methyl groups attached to histone proteins help switch genes on or off. Adding a methyl group to a lysine residue is a small chemical change — it does not alter the protein’s overall charge the way phosphorylation does — yet it can profoundly affect how proteins recognize one another, where they accumulate in the cell, and how long they persist. Because of this, methylation has primarily been studied as a form of epigenetic bookkeeping, a way of marking chromatin and controlling which genes are accessible. The LMU study adds a strikingly different context: methylation operating outside the nucleus, at the site of cytoskeletal assembly, coordinating the physical events that allow a parasite to begin moving. In this sense, the enzymes act less like gene regulators and more like construction foremen, ensuring that the right components arrive at the right place at the right time before the motility machinery can be switched on.

The importance of this coordination becomes clear when it fails. When the researchers removed PCKMT from T. gondii, the consequences were dramatic and cascading. Formin-1 no longer localized correctly to the parasite tip, actin assembly failed to initiate, and the parasites lost their ability to move efficiently. They could no longer exit the host cells they occupied, nor could they invade new ones. Each of these behaviors — gliding motility, egress, and invasion — depends on the same apical actin-based machinery, and all three collapsed when the methylation step was eliminated. The pattern of failure is itself informative. Because the defects appeared at the very beginning of the sequence, before actin filaments could form, the study could place PCKMT at an upstream, gating position in the pathway rather than among the downstream components of force generation.

This chain of defects underscores how tightly the steps of motility initiation are linked. A parasite preparing to move must first assemble actin filaments at its front end and then connect them to the force-generating apparatus. Without PCKMT, the first step never happens: the actin nucleator is not delivered to the tip, so no local filament network forms, and the conoid cannot protrude. Without the subsequent action of AKMT, even an assembled actin network cannot be properly coupled to force transmission. The two enzymes therefore appear to act in a defined order, with PCKMT setting the stage and AKMT completing the transition from a stationary, prepared parasite to a mechanically active one. Such temporal ordering is a recurring theme in cell biology, but demonstrating it in a parasite’s invasion machinery gives it particular practical weight, because it suggests multiple points at which intervention could stall the process.

The findings may extend beyond T. gondii. The team also examined P. falciparum, the species responsible for the most severe form of human malaria, and found that a related enzyme, PfSET9, localizes to the apical end of the parasite. When the researchers depleted PfSET9, invasion of red blood cells was strongly impaired. This parallel suggests that the regulatory principle discovered in T. gondii — apical methylation as a trigger for motility and invasion — may be conserved across apicomplexan parasites, the phylum that includes both organisms along with many other medically and veterinary important pathogens. A conserved mechanism is doubly significant: it hints at a shared vulnerability across related pathogens, and it suggests that insights gained in the genetically tractable T. gondii system can inform thinking about organisms that are harder to study in the laboratory.

Apicomplexan parasites are defined in part by their apical complex, an arrangement of structures at one end of the cell that orchestrates host cell invasion. These parasites rely on a distinctive form of gliding motility that does not involve flagella or cilia but instead depends on actin–myosin motors anchored beneath the parasite’s surface membrane. In this mode of movement, actin filaments are assembled at the parasite’s apex, linked to adhesion proteins that grip the substrate or host cell surface, and then dragged rearward by myosin motors, propelling the parasite forward. Because the parasites must invade host cells to survive and to complete their life cycles, blocking motility effectively blocks the infection cycle. That makes the molecular machinery of movement an attractive target for intervention — if it can be attacked selectively.

Here the study offers a potentially important lead. According to the researchers, the methyltransferases they characterized are specific to apicomplexan parasites, meaning they do not have direct equivalents performing the same role in human cells. Compounds that block the activity of these enzymes might therefore disrupt parasite movement and invasion while sparing the host’s own biology. This built-in selectivity is a valuable property in drug development, where off-target effects on the patient’s cells are a persistent concern. Enzymes that catalyze chemical modifications are also well-established drug targets in principle, since their active sites can often be blocked by small molecules that mimic or compete with their substrates. The enzymes could thus provide promising starting points for the design of new anti-parasitic drugs.

The need for new approaches is considerable. Malaria remains one of the world’s most devastating infectious diseases, and resistance to existing antimalarial drugs continues to emerge, forcing a continual search for targets with fresh mechanisms of action. Toxoplasma gondii, meanwhile, infects a large fraction of the human population worldwide, usually without symptoms, but it can cause severe disease in immunocompromised individuals and in unborn children when infection is acquired during pregnancy. Related apicomplexans impose heavy burdens on livestock, adding an agricultural dimension to the problem. A strategy that targets a conserved step in motility initiation, and one that is absent from human cells, could complement existing therapies and offer a route that parasites may find harder to circumvent, since the target sits at a bottleneck through which every invasive parasite must pass. A parasite that cannot move cannot invade, and a parasite that cannot invade cannot establish or propagate an infection.

Scientifically, the work also broadens the known repertoire of lysine methylation. By demonstrating that methyltransferases can act as spatial organizers of the cytoskeleton rather than solely as nuclear gene regulators, the study connects three domains that are usually treated separately: signaling, cytoskeletal activation, and mechanical force generation. The sequential action of PCKMT and AKMT suggests a temporal logic to motility initiation — first positioning the actin nucleation machinery, then enabling force coupling — that could serve as a model for how other motile cells, including possibly unrelated organisms, coordinate their own transitions from rest to movement. It also raises the question of whether similar non-nuclear methylation events await discovery in other systems, where they may have been overlooked because methylation has been sought primarily in the context of chromatin.

As with any study, questions remain. The work centers on T. gondii as the experimental system, with evidence in P. falciparum limited to the localization of PfSET9 and the effect of its depletion on invasion; the precise molecular targets of each methyltransferase, the identity of the lysine residues being modified, and the structural consequences of those modifications will require further investigation. The exact mechanism by which methylation of Formin-1 or its partners controls localization, and how AKMT-driven reorganization physically links actin to force transmission, are details that future studies will need to resolve. Whether the sequential logic observed in T. gondii maps one-to-one onto the malaria parasite also remains to be tested directly. Nevertheless, the central conclusion stands: methylation, an ancient chemical modification best known for silencing and activating genes, has been caught doing something entirely different in parasites — putting them in motion.